Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
31.16
+0.11 (0.35%)
Apr 28, 2026, 4:00 PM EDT - Market closed
HRMY Employees
Harmony Biosciences Holdings had 293 employees as of December 31, 2025. The number of employees increased by 25 or 9.33% compared to the previous year.
Employees
293
Change (1Y)
25
Growth (1Y)
9.33%
Revenue / Employee
$2,964,003
Profits / Employee
$541,594
Market Cap
1.80B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Vericel | 398 |
| Nurix Therapeutics | 317 |
| Nuvation Bio | 298 |
| Innoviva | 159 |
| Pharvaris | 129 |
| AnaptysBio | 104 |
| Taysha Gene Therapies | 99 |
HRMY News
- 5 days ago - Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 - Business Wire
- 12 days ago - Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual Meeting - Business Wire
- 14 days ago - Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer - Business Wire
- 15 days ago - Harmony Biosciences Holdings Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 26 days ago - Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board - Business Wire
- 4 weeks ago - Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference - Business Wire
- 7 weeks ago - Harmony Biosciences to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Harmony Biosciences Holdings Earnings Call Transcript: Q4 2025 - Transcripts